Covestor LTD Castle Biosciences Inc Transaction History
Covestor LTD
- $181 Million
- Q3 2025
A detailed history of Covestor LTD transactions in Castle Biosciences Inc stock. As of the latest transaction made, Covestor LTD holds 2,069 shares of CSTL stock, worth $50,090. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,069
Previous 2,380
13.07%
Holding current value
$50,090
Previous $49,000
4.08%
% of portfolio
0.03%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding CSTL
# of Institutions
170Shares Held
27.3MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY3.04MShares$73.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.17MShares$52.5 Million0.0% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.8MShares$43.6 Million0.02% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.49MShares$36.1 Million2.2% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.38MShares$33.4 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $637M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...